The liquid preparations may improve the ease and accuracy of drug administration ... about the use of sildenafil in a liquid form in patients requiring weight-based dosages and unable to swallow ...

The benefits do not stop there. Recent studies suggest GLP-1 drugs may also reduce the risk of heart disease, kidney disease and stroke, and even possibly protect the brain from AD by reducing ...

Pharmaceutical companies are demonstrating innovation by not only developing new drugs but also exploring combination therapies and ...

These were linked with about a 25 per cent lower death rate over the study, compared to similar women who did not take the hormone replacements, who were matched in terms of lifestyle factors such as ...

Among the total participants, 1,224 people, which is 8%, had a history of low-birth-weight delivery ... conducted by the University of Oxford in London found that the drug, called sildenafil, enhances ...

In fact, it’s safer than many other medicines like penicillin, Tylenol, and Viagra. Serious problems are rare ... You may need another dose of medicine or to have an in-clinic abortion to end the ...

Investors in weight-loss drug companies like Novo Nordisk and Eli Lilly face concerns over side effects and market ...

Several observations from preclinical and short-term clinical studies support a role for sildenafil in the treatment of heart failure patients. The following discussion briefly considers each of ...

Expanding Medicare to cover weight loss drugs would cost $35 billion over eight years, according to a new report from the ...

Are you running on empty? From low mood to libido or motivation, experts explain why you're operating at suboptimal levels, ...

Eli Lilly's weight-loss drug Zepbound and diabetes drug Mounjaro are no longer in shortage, the U.S. Food and Drug ...

Medicare coverage of weight loss drugs, if authorized, is seen increasing federal spending by about $35B from 2026 to 2034.